Share This Article:

Radioiodination of Cephalexin with 125I and Its Biological Behavior in Mice

Full-Text HTML Download Download as PDF (Size:558KB) PP. 97-102
DOI: 10.4236/pp.2012.31014    2,915 Downloads   6,080 Views   Citations


A procedure for radioiodination of Cephalexin with iodine-125 was carried out via an electrophilic substitution reaction. Using 3.7 MBq of Na125I, 200μl of cephalexin as substrate, 200 μl of iodogen as oxidizing agent in acetone at 40°C for 20 min, a maximum radiochemical yield of 125I-Ceph (95%) was obtained. The labeled compound was separated and purified by means of high-pressure liquid chromatography (HPLC). The biological distribution in normal and inflamed (septic and aseptic) mice indicates the suitability of radioiodinated cephalexin for imaging of inflammation

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

A. El-Bary, A. Amin, A. El-wetery, S. Saad and M. Shoukry, "Radioiodination of Cephalexin with 125I and Its Biological Behavior in Mice," Pharmacology & Pharmacy, Vol. 3 No. 1, 2012, pp. 97-102. doi: 10.4236/pp.2012.31014.


[1] W. Sneader, “Cephalosporin Analogues,” Wiley, 2005, New York, p. 324. doi:10.1002/0470015535
[2] The American Society of Health-System Pharmacists, “Cephalexin,” Retrieved 3 April 2011.
[3] M. E. Pichichero, “Use of Selected Cephalosporins in Penicillin-Allergic Patients: A Paradigm Shift,” Diagnostic Microbiology and Infectious Disease, Vol. 57, No. 3, 2007, pp. 13S-18S. doi:10.1016/j.diagmicrobio.2006.12.004
[4] F. Rojo, J. A. Ayala, E. J. de la Rosa , M. A. de Pedro, V. Arán, J. Berenguer and D. Vázquez, “Binding of 125I- Labeled Beta-Lactam Antibiotics to the Penicillin Binding Proteins of Escherichia Coli,” Journal of Antibiotics (Tokyo), Vol. 37, No. 4, 1984, pp. 389-393.
[5] D. A. Spyker, B. L. Thomas, M. A. Sande and W. K. Bolton, “Pharmacokinetics of Cefaclor and Cephalexin: Dosage Nomograms for Impaired Renal Function,” Antimicrob Agents Chemother, Vol. 14, No. 2, 1978, pp. 172-177.
[6] V. M. Shinde, B. S. Desai and N. M. Tendolkar, Indian Journal of Pharmaceutical Sciences, Vol. 56, No. 2, 1994, pp. 58-60.
[7] K. M. El-Azony, A. A. El-Mohty, H. M Killa., U. Seddik, and S. I. Khater, “An Investigation of the 125I-Radioiodination of Colchicine for Medical Purposes,” Journal of Labelled, Compounds and Radiopharmaceuticals, Vol. 52, No. 1, 2008, pp. 1-5.
[8] E. A. EL-Ghany, R. El-Sheikh, A. S. El-Wetery, A. Z. Saleh and H. Hussien, Arab Journal of Nuclear Sciences and Applications, Vol. 42, 2007, pp. 80.
[9] W. M. Hunter, Proceedings of the Society for Experimental Biology and Medicine, Vol. 133, 1970, pp. 989.
[10] V. Nara, V. Howell, R. Harapanhali, K. Sastry and D. Rao, Journal of Nuclear Medicine, Vol. 33, 1992, pp. 2196.
[11] W. G. Wood, C. Wachter and P. C. Scriba, “Comparison of 125I-Labelling of Polypeptides Using Chloramine-T and 1,3,4,6-Tetrachloro-3α,6α-diphenyl-glycoluril (Iodogen?) with Subsequent Separation of Iodide and Labelled Protein on Cation-Exchange Dextran,” Fresenius’ Journal of Analytical Chemistry, Vol. 301, No. 2, 1980, p. 119. doi:10.1007/BF00467765
[12] K. M. El-Azony, Arab Journal of Nuclear Sciences and Applications, Vol. 37, 2004, pp. 81.
[13] H. R. Adams, “Veterinary Pharmacology and Therapeutic,” 8th Edition, Wiley-Blackwell, New York, 2001, p. 21.
[14] J. C. Saccavini, C. Bruneau, IAEA-CN 4519, 1984, pp. 153.
[15] R. F. Verbruggen,“Kit Preparation and Rapid Quality Control of I-Labelled Hippuran,” International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, Vol. 37, No. 12, 1986, pp. 1249-1250. doi:10.1016/0883-2889(86)90017-1
[16] J. A. Davies and J. M. Holt, “Clinical Pharmacology of Cephalexin Administered by Intravenous Injection,” Journal of Clinical Pathology, Vol. 25, No. 6, 1972, pp. 518-520. doi:10.1136/jcp.25.6.518

comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.